Remove 2023 Remove Diagnosis Remove Individual Remove Patients
article thumbnail

Assessment of Project ECHO(R) Opioid Use Disorder Sessions for Primary Care Teams [Education and training]

Annals of Family Medicine

Unfortunately, most individuals suffering from OUD do not have access to necessary care. A critical shortage of clinicians who specialize in treating patients with OUD exacerbates this issue. Intervention: 12 monthly online OUD sessions held from April 2023 to March 2024.

article thumbnail

Hepatitis C Micro-elimination Using Patient Navigation In a Regional Healthcare System [Infectious diseases (not respiratory tract)]

Annals of Family Medicine

Micro-elimination projects aim to selectively foster diagnosis, treatment and reinfection of high priority demographic groups. A small-scale, peer navigation focused micro-elimination project was launched to facilitate treatment engagement and re-testing for individuals experiencing elevated risk of HCV re-infection. were female, 74.4%

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The utilization patterns and impact of the Stanford Chronic Pain Self-Management Program in Eastern Ontario, Canada [Pain management]

Annals of Family Medicine

Context Healthcare providers often struggle to treat patients with chronic pain. One potential solution is to facilitate patient access to programs that develop skills and confidence in managing their own care. Dataset: We used data routinely collected through the CPSMP between December 2017 and May 2023.

article thumbnail

Prescribing Red Flags and Suspicious Controlled Substance Orders: Current Cautionary Tales

FDA Law Blog

11, 2023 ( DOJ Press Release ). 6, 2023 ( DOJ Press Release ). Pharmacists’ Corresponding Responsibility A controlled substance prescription, to be valid, must be issued for “a legitimate medical purpose by an individual practitioner acting in the usual course of [their] professional practice.” Complaint ¶ 58. Complaint ¶ 59.

article thumbnail

A Long Time Coming: DEA Regs Finally Authorize Schedule II Prescription Partial Fills

FDA Law Blog

CARA amended the Controlled Substances Act (“CSA”) to enable physicians or patients to request pharmacists to partially fill prescriptions for schedule II substances including opioids and to allow remaining quantities to be filled up to 30 days after issuance of the prescription (up to 72 hours for emergency oral prescriptions). 21 U.S.C. §

article thumbnail

You don’t need labs to medically clear a psych patient

PEMBlog

This is a blog post designed to disseminate the important work of Choosing Wisely , an initiative of the the American Board of Internal Medicine Foundation, the goal of which is the spark conversations between clinicians and patients about what tests, treatments, and procedures are needed – and which ones are not.

article thumbnail

Prescribing Red Flags: Pharmacists Be Wary of What the Doctor Orders

FDA Law Blog

86, 72703 (December 22, 2021), DEA emphasized in the Gulf Med decision that prescribing [r]ed flags are circumstances surrounding a prescription that cause a pharmacist to take pause, including signs of diversion or the potential for patient harm. Patients filling prescriptions at the same time at multiple pharmacies. 81, 86, 251.